Advertisement
Health Care And Privilege: Why Many Americans Can't Access The Same COVID-19 Treatment As Trump
Resume
Regeneron Pharmaceuticals says fewer than 10 people have been given an experimental antibody cocktail it gave President Trump to fight the coronavirus.
Here & Now's Tonya Mosley speaks with STAT reporter Casey Ross about the company's decision and challenges for other Americans who qualify but can't access treatment.
This segment aired on October 7, 2020.